menu close
www.arsenalbio.com

ArsenalBio Stock

Company Profile:

ArsenalBio is building a programmable cell therapy company to create highly effective and accessible immune cell therapies to impact outcomes for a much broader number of patients, initially those with cancer. ArsenalBio is focused on integrating technologies such as CRISPR-based genome engineering, scaled and high throughput target identification, synthetic biology, and machine learning to advance a new paradigm to discover and develop in immune cell therapies. With its programmable and computationally driven approach, ArsenalBio aspires to evolve critical metrics of success for immune cell therapies, including enhanced and broader efficacy, increased patient safety, reduced provider costs, and expanded market access.

Sign up for SecondMarket™ to view the market and buy or sell ArsenalBio Stock
Buy + Sell

ArsenalBio Funding

Sign up to gain insights into ArsenalBio funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Jul 09, 2024 Series C 297.50M
Price
Valuation
May 31, 2022 Series B 88.81M
Price
Valuation
Feb 10, 2022 Series B 99.00M
Price
Valuation
Dec 14, 2020 Series B 33.00M
Price
Valuation
Oct 17, 2019 Series A 85.00M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

ArsenalBio Management Team

  • Director

    Matthew K. Fust

  • Director

    Brook Byers

  • Chief Technology Officer

    Tarjei Mikkelsen

  • Chief People Officer

    Bee Nguyen

  • Co-Founder, CEO, Chairman

    Ken Drazan

  • Director

    Sean Parker

  • Director

    Valentin Barsan

  • Director

    Beth Seidenberg

  • Chief Scientific Officer

    W. Nicholas Haining

  • Chief Medical Officer

    Susie Jun

  • Chief Technical Operations Officer

    Tim Sirichoke

ArsenalBio Major Investors

  • Bristol-Myers Squibb Company

  • Byers Capital

  • Emerson Collective LLC

  • Euclidean Capital

  • Green Sands Equity

  • Hitachi America, Ltd.

  • Kleiner Perkins Caufield & Byers LLC (KPCB)

  • Osage Partners LLC

  • Sixth Street Partners

  • Softbank Vision Fund 2

  • The Parker Institute for Cancer Immunotherapy

  • UCSF Foundation Investment Company

  • Waycross Ventures

  • Westlake Village BioPartners

Learn More About ArsenalBio Stock

Buy ArsenalBio Stock
01
ArsenalBio stock does not trade on public stock exchanges. ArsenalBio stock is considered a private security and you need to be an accredited investor to purchase shares. To invest in ArsenalBio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market. Get started to begin exploring private market opportunities.
Sell ArsenalBio Stock
02
ArsenalBio Stock does not trade on public stock exchanges. In order to sell ArsenalBio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors. Get started to begin exploring private market opportunities.
ArsenalBio Stock Price
03
ArsenalBio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view ArsenalBio share price and other valuable private market data. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
ArsenalBio Stock Ticker Symbol
04
There is no ticker symbol for ArsenalBio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company “street” name or legal name. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Criteria to Sell ArsenalBio Stock
05
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell ArsenalBio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Criteria to Buy or Invest in ArsenalBio Stock
06
Currently, Nasdaq Private Market only works with institutional investors to purchase private company stock. In order to invest in ArsenalBio stock you need to be an institutional investor. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
ArsenalBio Stock Settlement
07
Once you buy or sell stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
ArsenalBio IPO
08
ArsenalBio is a private company and has not had an IPO. There is currently no ArsenalBio IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to ArsenalBio IPO.
Sign up for SecondMarket™ to view the market and buy or sell ArsenalBio Stock
Buy + Sell

Other Companies

PineLabs

Point of sale and payment systems for businesses.

SourceGraph

A search engine that allows users to search for code.

Verbit

AI powered transcription and captioning platform.

Pilot.com

Book-keeping services for startups and other small businesses.

Firebolt

A cloud data warehouse with sub-second performance at terabyte scale, designed for next-gen analytics experiences.

Sigma Computing

Develops analytics tools for cloud data warehouses, enabling users to create formulas, charts and dashboards.

Source: Nasdaq Private Market Tape D™